We have identified a potentially therapeutic anti-human immunodeficiency virus (HIV)-1 oligonucleotide composed entirely of deoxyguanosines and thymidines (T30177, also known as AR177: 5`-g*tggtgggtgggtggg*t-3`, where asterisk indicates phosphorothioate linkage). In acute assay systems using human T-cells, T30177 and its total phosphodiester homologue T30175 inhibited HIV-1-induced syncytium production by 50% at 0.15 and 0.3 µM, respectively. Under physiological conditions, the sequence and composition of the 17-mer favors the formation of a compact, intramolecularly folded structure dominated by two stacked guanine quartet motifs that are connected by three loops of TGs. The molecule is stabilized by the coordination of a potassium ion between the two stacked quartets. We now show that these guanine quartet-containing oligonucleotides are highly resistant to serum nucleases, with tof 5 h and >4 days for T30175 and T30177, respectively. Both oligonucleotides were internalized efficiently by cells, with intracellular concentrations reaching 5-10-fold above the extracellular levels after 24 h of incubation. In contrast, single-base mutated variants or random sequence control oligonucleotides that could not form the compactly folded structure had markedly reduced half-lives (tfrom 3 to 7 min), low cellular uptake, and no sequence-specific anti-HIV-1 activity. These data suggest that the tertiary structure of an oligonucleotide is a key determinant of its nuclease resistance, cellular uptake kinetics, and biological efficacy.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				N. Jing, Q. Zhu, P. Yuan, Y. Li, L. Mao, and D. J. Tweardy Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol. Cancer Ther., February 1, 2006; 5(2): 279 - 286. [Abstract] [Full Text] [PDF]

				K. S. Schmidt, S. Borkowski, J. Kurreck, A. W. Stephens, R. Bald, M. Hecht, M. Friebe, L. Dinkelborg, and V. A. Erdmann Application of locked nucleic acids to improve aptamer in vivo stability and targeting function Nucleic Acids Res., October 27, 2004; 32(19): 5757 - 5765. [Abstract] [Full Text] [PDF]

				N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis Cancer Res., September 15, 2004; 64(18): 6603 - 6609. [Abstract] [Full Text] [PDF]

				T. Kuwasaki, M. Hatta, H. Takeuchi, and H. Takaku Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs J. Antimicrob. Chemother., April 1, 2003; 51(4): 813 - 819. [Abstract] [Full Text] [PDF]

				J.-i. Suzuki, N. Miyano-Kurosaki, T. Kuwasaki, H. Takeuchi, G. Kawai, and H. Takaku Inhibition of Human Immunodeficiency Virus Type 1 Activity In Vitro by a New Self-Stabilized Oligonucleotide with Guanosine-Thymidine Quadruplex Motifs J. Virol., February 22, 2002; 76(6): 3015 - 3022. [Abstract] [Full Text] [PDF]

				K. H. Baek, S. J. Ha, and Y. C. Sung A Novel Function of Phosphorothioate Oligodeoxynucleotides as Chemoattractants for Primary Macrophages J. Immunol., September 1, 2001; 167(5): 2847 - 2854. [Abstract] [Full Text] [PDF]

				S. W. Lee, M. K. Song, K. H. Baek, Y. Park, J. K. Kim, C. H. Lee, H.-K. Cheong, C. Cheong, and Y. C. Sung Effects of a Hexameric Deoxyriboguanosine Run Conjugation into CpG Oligodeoxynucleotides on Their Immunostimulatory Potentials J. Immunol., October 1, 2000; 165(7): 3631 - 3639. [Abstract] [Full Text] [PDF]

				T. L. Wallace, C. Gamba-Vitalo, K. S. Loveday, and P. A. Cossum Acute, Multiple-Dose, and Genetic Toxicology of AR177, an Anti-HIV Oligonucleotide Toxicol. Sci., January 1, 2000; 53(1): 63 - 70. [Abstract] [Full Text] [PDF]

				E. Blum, A. J. Carpousis, and C. F. Higgins Polyadenylation Promotes Degradation of 3'-Structured RNA by the Escherichia coli mRNA Degradosome in Vitro J. Biol. Chem., February 12, 1999; 274(7): 4009 - 4016. [Abstract] [Full Text] [PDF]

				P. Cherepanov, J. A. Esté, R. F. Rando, J. O. Ojwang, G. Reekmans, R. Steinfeld, G. David, E. De Clercq, and Z. Debyser Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1 Mol. Pharmacol., November 1, 1997; 52(5): 771 - 780. [Abstract] [Full Text]

				A. Mazumder, H. Uchida, N. Neamati, S. Sunder, M. Jaworska-Maslanka, E. Wickstrom, F. Zeng, R. A. Jones, R. F. Mandes, H. K. Chenault, et al. Probing Interactions between Viral DNA and Human Immunodeficiency Virus Type 1 Integrase Using Dinucleotides Mol. Pharmacol., April 1, 1997; 51(4): 567 - 575. [Abstract] [Full Text]

				T. L. Wallace, S. A. Bazemore, K. Holm, P. M. Markham, J. P. Shea, N. Chaudhary, and P. A. Cossum Pharmacokinetics and Distribution of a 33P-labeled Anti-Human Immunodeficiency Virus Oligonucleotide (AR177) after Single- and Multiple-Dose Intravenous Administration to Rats J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1480 - 1488. [Abstract] [Full Text]

				C. Giovannangeli, S. Diviacco, V. Labrousse, S. Gryaznov, P. Charneau, and C. Helene Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target PNAS, January 7, 1997; 94(1): 79 - 84. [Abstract] [Full Text] [PDF]